Arbutus Biopharma Corp: director Robert A Beardsley sold 17,948 shares

What happened

• The filing reports that Robert A Beardsley, a director, disposed of 17,948 common shares to the issuer at $5.00 per share on Oct 1, 2026, for $89,740. The transaction is reported on a Form 4 filed on Oct 7, 2026.
• The Form 4 lists the transaction as a disposition to the issuer (code D).

Key details

• Transaction date and price: Oct 1, 2026 at $5.00 per share.
• Total shares disposed: 17,948 for $89,740.
• Shares owned after the transaction: not reported in the filing provided.
• Footnote F1: "Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on Oct 1, 2026."
• Filing timeliness: the Form 4 was filed on Oct 7, 2026 (timeliness status not indicated in the provided summary).

Why it may matter

• The filing indicates these shares were tendered to the issuer as part of the issuer's tender offer and therefore were not sold on the open market.
• This filing does not show why the insider traded or why the company acted.